Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.05 and traded as high as $6.7442. Aspen Pharmacare shares last traded at $6.7442, with a volume of 130 shares.
Aspen Pharmacare Stock Up 0.1%
The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.18 and a current ratio of 2.21. The stock has a 50 day moving average of $6.38 and a 200 day moving average of $6.05.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Read More
- Five stocks we like better than Aspen Pharmacare
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
- He just nailed another gold prediction …
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
